Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 2019 August;60(4) > The Journal of Cardiovascular Surgery 2019 August;60(4):450-5

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

 

REVIEW  RECENT DEVELOPMENTS IN DES FOR LONG LESIONS 

The Journal of Cardiovascular Surgery 2019 August;60(4):450-5

DOI: 10.23736/S0021-9509.19.10984-6

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Inglese

The current state of surgical bypass versus drug eluting stents for long femoropopliteal occlusive lesions

Waka YANAGISAWA 1, Miguel L. GOMES 1, Theo P. MENTING 1, Koen R. DE LOOSE 2, Ramon L. VARCOE 1, 2, 3

1 Department of Surgery, Prince of Wales Hospital, Sydney, Australia; 2 Department of Vascular Surgery, AZ Sint Blasius Hospital, Dendermonde, Belgium; 3 Faculty of Medicine, University of New South Wales, Sydney, Australia



Considerable advances have been made over the last decade in the management of patients with peripheral artery disease. Historically, endovascular treatment has been the accepted approach for short lesions and surgical bypass for long, complex femoropopliteal lesions. However, bypass surgery holds significant risk of mortality and morbidity for the patient. That toll includes prolonged hospitalization, as well as the potential for wound healing and systemic complications, all of which are intensified by the ageing population. Advances in endovascular devices, such as drug eluting stents present an alternative, minimally invasive treatment option which may more suitable for complex lesions in a high-risk population. The aim of this review is to discuss the current literature which addresses surgical bypass and drug eluting stents, particularly for the treatment of long, complex femoropopliteal disease.


KEY WORDS: Peripheral artery disease; Stents; Surgery

inizio pagina